Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$200.97 USD
-0.96 (-0.48%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $200.78 -0.19 (-0.09%) 7:58 PM ET
5-Strong Sell of 5 5
B Value C Growth B Momentum B VGM
Brokerage Reports
Charles River Laboratories International, Inc. [CRL]
Reports for Purchase
Showing records 341 - 360 ( 386 total )
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Healthcare IT, Biopharmaceutical Services and Laboratories: Post-1Q17 Model Book
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Healthcare IT, Biopharmaceutical Services and Laboratories: Post-4Q16 Model Book
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS